Copyright Reports & Markets. All rights reserved.

Global Leishmaniasis Treatment Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Leishmaniasis Treatment Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Meglumine Antimoniate
    • 1.2.3 Pentamidine
    • 1.2.4 Hydroxyl Amidine Stilbene
    • 1.2.5 Amphotericin B
  • 1.3 Market by Application
    • 1.3.1 Global Leishmaniasis Treatment Market Share by Application: 2020 VS 2026
    • 1.3.2 Visceral Leishmaniasis
    • 1.3.3 Cutaneous Leishmaniasis
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Leishmaniasis Treatment Market Perspective (2015-2026)
  • 2.2 Global Leishmaniasis Treatment Growth Trends by Regions
    • 2.2.1 Leishmaniasis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Leishmaniasis Treatment Historic Market Share by Regions (2015-2020)
    • 2.2.3 Leishmaniasis Treatment Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Leishmaniasis Treatment Players by Market Size
    • 3.1.1 Global Top Leishmaniasis Treatment Players by Revenue (2015-2020)
    • 3.1.2 Global Leishmaniasis Treatment Revenue Market Share by Players (2015-2020)
  • 3.2 Global Leishmaniasis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Leishmaniasis Treatment Revenue
  • 3.4 Global Leishmaniasis Treatment Market Concentration Ratio
    • 3.4.1 Global Leishmaniasis Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Leishmaniasis Treatment Revenue in 2019
  • 3.5 Key Players Leishmaniasis Treatment Area Served
  • 3.6 Key Players Leishmaniasis Treatment Product Solution and Service
  • 3.7 Date of Enter into Leishmaniasis Treatment Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Leishmaniasis Treatment Breakdown Data by Type (2015-2026)

  • 4.1 Global Leishmaniasis Treatment Historic Market Size by Type (2015-2020)
  • 4.2 Global Leishmaniasis Treatment Forecasted Market Size by Type (2021-2026)

5 Leishmaniasis Treatment Breakdown Data by Application (2015-2026)

  • 5.1 Global Leishmaniasis Treatment Historic Market Size by Application (2015-2020)
  • 5.2 Global Leishmaniasis Treatment Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Leishmaniasis Treatment Market Size (2015-2026)
  • 6.2 North America Leishmaniasis Treatment Market Size by Type (2015-2020)
  • 6.3 North America Leishmaniasis Treatment Market Size by Application (2015-2020)
  • 6.4 North America Leishmaniasis Treatment Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Leishmaniasis Treatment Market Size (2015-2026)
  • 7.2 Europe Leishmaniasis Treatment Market Size by Type (2015-2020)
  • 7.3 Europe Leishmaniasis Treatment Market Size by Application (2015-2020)
  • 7.4 Europe Leishmaniasis Treatment Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Leishmaniasis Treatment Market Size (2015-2026)
  • 8.2 China Leishmaniasis Treatment Market Size by Type (2015-2020)
  • 8.3 China Leishmaniasis Treatment Market Size by Application (2015-2020)
  • 8.4 China Leishmaniasis Treatment Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Leishmaniasis Treatment Market Size (2015-2026)
  • 9.2 Japan Leishmaniasis Treatment Market Size by Type (2015-2020)
  • 9.3 Japan Leishmaniasis Treatment Market Size by Application (2015-2020)
  • 9.4 Japan Leishmaniasis Treatment Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Leishmaniasis Treatment Market Size (2015-2026)
  • 10.2 Southeast Asia Leishmaniasis Treatment Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Leishmaniasis Treatment Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Leishmaniasis Treatment Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

  • 11.1 Merck
    • 11.1.1 Merck Company Details
    • 11.1.2 Merck Business Overview
    • 11.1.3 Merck Leishmaniasis Treatment Introduction
    • 11.1.4 Merck Revenue in Leishmaniasis Treatment Business (2015-2020))
    • 11.1.5 Merck Recent Development
  • 11.2 iCo Therapeutics
    • 11.2.1 iCo Therapeutics Company Details
    • 11.2.2 iCo Therapeutics Business Overview
    • 11.2.3 iCo Therapeutics Leishmaniasis Treatment Introduction
    • 11.2.4 iCo Therapeutics Revenue in Leishmaniasis Treatment Business (2015-2020)
    • 11.2.5 iCo Therapeutics Recent Development
  • 11.3 AEterna Zentaris
    • 11.3.1 AEterna Zentaris Company Details
    • 11.3.2 AEterna Zentaris Business Overview
    • 11.3.3 AEterna Zentaris Leishmaniasis Treatment Introduction
    • 11.3.4 AEterna Zentaris Revenue in Leishmaniasis Treatment Business (2015-2020)
    • 11.3.5 AEterna Zentaris Recent Development
  • 11.4 AEterna Zentaris AG
    • 11.4.1 AEterna Zentaris AG Company Details
    • 11.4.2 AEterna Zentaris AG Business Overview
    • 11.4.3 AEterna Zentaris AG Leishmaniasis Treatment Introduction
    • 11.4.4 AEterna Zentaris AG Revenue in Leishmaniasis Treatment Business (2015-2020)
    • 11.4.5 AEterna Zentaris AG Recent Development
  • 11.5 Eurofins Advinus
    • 11.5.1 Eurofins Advinus Company Details
    • 11.5.2 Eurofins Advinus Business Overview
    • 11.5.3 Eurofins Advinus Leishmaniasis Treatment Introduction
    • 11.5.4 Eurofins Advinus Revenue in Leishmaniasis Treatment Business (2015-2020)
    • 11.5.5 Eurofins Advinus Recent Development
  • 11.6 Pieris Pharmaceuticals
    • 11.6.1 Pieris Pharmaceuticals Company Details
    • 11.6.2 Pieris Pharmaceuticals Business Overview
    • 11.6.3 Pieris Pharmaceuticals Leishmaniasis Treatment Introduction
    • 11.6.4 Pieris Pharmaceuticals Revenue in Leishmaniasis Treatment Business (2015-2020)
    • 11.6.5 Pieris Pharmaceuticals Recent Development
  • 11.7 Dafra Pharma
    • 11.7.1 Dafra Pharma Company Details
    • 11.7.2 Dafra Pharma Business Overview
    • 11.7.3 Dafra Pharma Leishmaniasis Treatment Introduction
    • 11.7.4 Dafra Pharma Revenue in Leishmaniasis Treatment Business (2015-2020)
    • 11.7.5 Dafra Pharma Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Leishmaniasis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Leishmaniasis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Meglumine Antimoniate
    Pentamidine
    Hydroxyl Amidine Stilbene
    Amphotericin B

    Market segment by Application, split into
    Visceral Leishmaniasis
    Cutaneous Leishmaniasis

    Based on regional and country-level analysis, the Leishmaniasis Treatment market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Leishmaniasis Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Merck
    iCo Therapeutics
    AEterna Zentaris
    AEterna Zentaris AG
    Eurofins Advinus
    Pieris Pharmaceuticals
    Dafra Pharma
    Buy now